All posts tagged
Europe Turns the Tables in the CRISPR Patent Battle
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
More News! Is CRISPR better than TALEN for CAR-T?
More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The UK Steps Up its Game in Automated CRISPR Gene Editing
Europe’s Lag in the Gene Editing Race may leave its Biotech Obsolete
‘Packaged’ CRISPR Systems to Standardize novel Biomedical Research
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
These are our 10 Most Read Biotech Articles of 2016
Labiotech UG, All Rights Reserved -
Send this to friend